Bharat Biotech to cut malaria vaccine RTS.S price to under USD 5 for children in endemic countries Ruchika Sharma25 Jun 2025 2:54 PM ISTHyderabad: Bharat Biotech will be reducing the price of world's first malaria vaccine RTS.S, developed by GSK, PATH and...
GSK application for expanded use of RSV vaccine in adults aged 18-49 accepted in Japan Ruchika Sharma22 Jun 2025 11:30 AM ISTGSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted the company's regulatory application to expand the use...
GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older Ruchika Sharma15 Jun 2025 10:00 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to expand the use...
GSK Linerixibat application for cholestatic pruritus in primary biliary cholangitis patients under USFDA review Ruchika Sharma3 Jun 2025 2:15 PM ISTLondon: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ileal bile...
GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myeloma Ruchika Sharma25 May 2025 1:30 PM ISTGSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of...
GSK Nucala wins USFDA OK for use in adults with COPD Ruchika Sharma23 May 2025 12:17 PM ISTLondon: GSK plc has received approval from the US Food and Drug Administration (FDA) for Nucala (mepolizumab) as an add-on maintenance treatment for...
GSK Blenrep combos win approval in Japan for multiple myeloma Ruchika Sharma20 May 2025 1:45 PM ISTGSK plc has received approval for Blenrep combinations from Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of adults with...
GSK to acquire liver disease drug Efimosfermin for up to USD 2 billion Ruchika Sharma15 May 2025 4:10 PM ISTLondon: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies for patients with...
GSK, partner iTeos end development programme for lung cancer drug belrestotug Ruchika Sharma14 May 2025 2:30 PM ISTGSK plc with its development partner iTeos Therapeutics, Inc., has announced that it is ending the development programme for experimental lung cancer...
GSK Blenrep combinations approved by UK MHRA in relapsed/refractory multiple myeloma Ruchika Sharma20 April 2025 10:00 AM ISTGSK plc has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Blenrep. In the UK, Blenrep is...
GSK Arexvy recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices Ruchika Sharma20 April 2025 9:00 AM ISTGSK plc has announced that the Advisory Committee on Immunization Practices (ACIP) voted in favour of recommending the use of RSV vaccines including...
GSK in breach for misleading prescription information on Omjjara: industry body Ruchika Sharma16 April 2025 2:34 PM ISTLondon: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards in the marketing and...
